Download PDF
Arzneimittelforschung 2008; 58(10): 505-509
DOI: 10.1055/s-0031-1296549
Antihypertensives
Editio Cantor Verlag Aulendorf (Germany)

Efficacy and Safety of Benidipine Therapy of Essential Hypertension in Elderly Chinese Patients

Hai-Ya Wang
1   Geriatric Department Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, The People’s Republic of China
,
Chuan-Fu Wang
2   Geriatric Department Hua Dong Hospital, Fudan University Shanghai, The People’s Republic of China
,
Zhi-Hong Pan
3   Geriatric Department Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, The People’s Republic of China
,
Han Wu
4   Geriatric Department, Shanghai Jiao Tong University Affiliated First People’s Hospital, Shanghai, The People’s Republic of China
,
Yuan Zhong
5   Geriatric Department, Shanghai No.6 People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, The People’s Republic of China
,
Xian-Chuan Chen
6   Geriatric Department, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, The People’s Republic of China
,
Shu-Hua Zhang
7   Geriatric Department, Shanghai Tenth People’s Hospital affiliated to Tongji University, Shanghai, The People’s Republic of China
,
Hua Zhang
8   Geriatric Department Shanghai Dongfang Hospital, Shanghai, The People’s Republic of China
,
Ning-Yuan Fang
1   Geriatric Department Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, The People’s Republic of China
› Author Affiliations
Further Information

Publication History

Publication Date:
19 December 2011 (online)

    Permissions and Reprints

Abstract

Background:

Benidipine (CAS 105979-17-7) is a dihydropyridine calcium channel blocker used in the treatment of hypertension and angina pectoris.

Objective:

To examine the efficacy and safety of therapy with benidipine in elderly hypertensive patients.

Methods:

Chinese patients > 60 years of age with mild to moderate essential hypertension were enrolled. The patients were prescribed benidipine at the dose of 8 mg once daily for 12 weeks. Detailed laboratory examinations and 24-h ambulatory blood pressure monitoring were performed before and after the treatment.

Results:

One hundred and sixty-four of the 180 patients enrolled completed the 12-week active treatment phase. Sitting systolic blood pressure (SBP) and diastolic blood pressure (DBP) reductions at the end of treatment were 21.50 ± 12.83 and 10.60 ± 8.04 mmHg, respectively; the proportion of patients showing a good treatment response was 95.1% for SBP and 96.9% for DBP. Benidipine significantly reduced the mean 24-h ambulatory blood pressure (p<0.001 vs. baseline) exhibiting smooth, sustained effects and high trough-to-peak ratios (T/P ratio) (0.87 for SBP and 0.72 for DBP). Moreover, benidipine significantly reduced the systolic morning blood pressure surge and urinary albumin, and it was well tolerated. No serious adverse events were noted.

Conclusion:

Benidipine was well tolerated and effective in elderly Chinese patients with essential hypertension.

Key words

Antihypertensives - Benidipine, efficacy, safety - Calcium channel blockers, dihydropyridine - CAS 105979-17-7
 

  • References

  • 1 Yamashita T, Kawashima S, Ozaki M, Rikitake Y, Hirase T, Inoue N et al. A calcium channel blocker, benidipine, inhibits intimal thickening in the carotid artery of mice by increasing nitric oxide production. J Hypertens. 2001; 19: 451-458
    CrossrefPubMedGoogle Scholar
  • 2 Saito F, Fujita H, Takahashi A, Ichiyama I, Harasawa S, Oiwa K. Renoprotective effect and cost-effectiveness of using benidipine, a calcium channel blocker, to lower the dose of angiotensin receptor blocker in hypertensive patients with albuminuria. Hypertens Res. 2007; 30: 39-47
    CrossrefPubMedGoogle Scholar
  • 3 Tsuda K, Nishio I. A calcium channel blocker, benidipine, improves cell membrane fluidity in human subjects via a nitric oxide-dependent mechanism. An electron paramagnetic resonance investigation. Am J Hypertens. 2004; 17: 1143-1150
    CrossrefPubMedGoogle Scholar
  • 4 Suzuki H, Yokoyama K, Akimoto Y, Daida H. Clinical efficacy of benidipine for vasospastic angina pectoris. Arzneimittel-Forschung (Drug Research). 2007; 57: 20-5
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Li Y, Wang JG, Dolan E, Gao PJ, Guo HF, Nawrot T et al. Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension. 2006; 47: 359-364
    CrossrefPubMedGoogle Scholar
  • 6 Manfredini R, Boari B, Portaluppi F. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation. 2003; 108: e72-73
    CrossrefPubMedGoogle Scholar
  • 7 Tseng YZ. Applications of 24-hour noninvasive ambulatory blood pressure monitoring. J Formos Med Assoc. 2006; 105: 955-963
    CrossrefPubMedGoogle Scholar
  • 8 Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens. 1998; 16: 1685-1691
    CrossrefPubMedGoogle Scholar
  • 9 Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Blood Pressure Monitoring. Task Force V: White-coat hypertension. Blood Press Monit. 1999; 4: 333-341
    PubMedGoogle Scholar
  • 10 Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-1913
    CrossrefPubMedGoogle Scholar
  • 11 Veerman DP, de Blok K, van Montfrans A. Relationship of steady state and ambulatory blood pressure variability to left ventricular mass and urinary albumin excretion in essential hypertension. Am J Hypertens. 1996; 9: 455-460
    CrossrefPubMedGoogle Scholar
  • 12 Nakajima O, Akioka H, Miyazaki M. Effect of the calcium antagonist benidipine hydrochloride on 24-h ambulatory blood pressure in patients with mild to moderate hypertension in a double-blind study against placebo. Arzneimittel-Forschung (Drug Research). 2000; 50: 620-625
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Wang F, Kan LM, Huang J, Wang L, Bian WY, Chen XR et al. Effect of Benidipine hydrochloride on blood pressure in patients with hypertension assessed by ambulatory blood pressure. Chin J Hypertens. 2004; 12: 303-306
    PubMedGoogle Scholar
  • 14 Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol. 1987; 60: 801-806
    CrossrefPubMedGoogle Scholar
  • 15 Kario K, Shimada K, Pickering TG. Clinical implication of morning blood pressure surge in hypertension. J Cardiovasc Pharmacol. 2003; 42: S87-91
    CrossrefPubMedGoogle Scholar
  • 16 Kita T, Suzuki Y, Eto T, Kitamura K. Long-term anti-hypertensive therapy with benidipine improves arterial stiffness over blood pressure lowering. Hypertens Res. 2005; 28: 959-64
    CrossrefPubMedGoogle Scholar
  • 17 Uzu T, Nishimura M, Fujii T, Sakaguchi M, Kanasaki M, Isshiki K. Benidipine attenuates glomerular hypertension and reduces albuminuria in patients with metabolic syndrome. Hypertens Res. 2007; 30: 161-165
    CrossrefPubMedGoogle Scholar